Essex Woodlands Management as of June 30, 2018
Portfolio Holdings for Essex Woodlands Management
Essex Woodlands Management holds 8 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Axogen (AXGN) | 43.3 | $187M | 3.7M | 50.25 | |
| Revance Therapeutics (RVNC) | 21.3 | $92M | 3.3M | 27.45 | |
| Corium Intl | 17.4 | $75M | 9.4M | 8.01 | |
| pSivida | 12.3 | $53M | 26M | 2.08 | |
| Endologix | 3.2 | $14M | 1.3M | 10.83 | |
| MediciNova (MNOV) | 2.2 | $9.3M | 1.2M | 7.96 | |
| Catalyst Biosciences | 0.2 | $933k | 79k | 11.87 | |
| Acura Pharmaceuticals (ACUR) | 0.2 | $704k | 2.0M | 0.36 |
